Skip to main content
. 2021 Apr 9;12:661911. doi: 10.3389/fimmu.2021.661911

Figure 2.

Figure 2

Declined graft function and survival rate in CAAMR and CAMR patients. The serum creatinine (A, B) and eGFR (C, D) in all patients (Control, CAAMR, CAMR) were collected and analyzed at the time of diagnosis of rejection and from one year before biopsy to one year after biopsy. Kaplan-Meier survival analysis was used to compare the biopsy time to allograft failure between the three groups with the log-rank test (E). Cre, creatinine; eGFR, estimated glomerular filtration rate. *p ≤ 0.05, **p ≤ 0.01. ns, no significance.